SlideShare a Scribd company logo
1
Copyright © Veeva Systems 2021
Reshaping Global ICSR Reporting to
Deliver Real-time Visibility and Oversight
Saba Darvesh, Sr. Director Vault Safety Strategy
Mike Kruczek, Director Vault Safety Strategy
Saba Darvesh
Sr. Director, Vault Safety Strategy
Mike Kruczek
Director, Vault Safety Strategy
Global ADR
Data and Trends
4
Copyright © Veeva Systems 2021
ICSR Volume Data
FDA FAERS Public Dashboard (Mar 2021)
5
Copyright © Veeva Systems 2021
ICSR Volume Data
EMA PV Annual Report (2020)
Figure 2 – Trend of ADR reports from patients and consumers received
in the EEA by NCAs and MAHs and reported to EudraVigilance
EudraVigilance continues to
support the reporting of suspected
unexpected serious adverse
reactions (SUSARs) in accordance
with EU clinical trial legislation14
(see Annex II)
6
Copyright © Veeva Systems 2021
ICSR Volume Data
NMPA PV Annual Report (2020)
1800000
1600000
1400000
1200000
1000000
800000
600000
400000
200000
0
Figure 1 - Trend in the number of reported adverse drug reactions / events nationwide from 1999 to 2020
Figure 3 - Source of adverse drug
event reports for 2020
7
Copyright © Veeva Systems 2021
Uppsala Monitoring Centre
Annual Report Jul 2019 – Jun 2020
Additional Statistics from VigiBase
Country distribution for ICSRs received over the year
Country distribution in VigiBase for ICSRs received
during the past 12 months, as of 30 June 2020
ICSRs per Million Inhabitants
ICSRs received in VigiBase 2015 – 2020
(average to compensate for year-to-year fluctuations)
A Rapidly Evolving
Global Reporting Landscape
9
Copyright © Veeva Systems 2021
Evolving Global Reporting Landscape
Evolving Regulatory
Guidelines
File
Formats
Data Integrity
and Timeliness
Solicited
Monitoring
Unsolicited
Monitoring
(PSP’s, SM, MLM)
Data Quality
Enhanced
Oversight and
Management
10
Copyright © Veeva Systems 2021
Evolving Global Regulatory Landscape
2001
EudraVigilance
Created
2012 2017 2018 2019 2020 2021
New EU GPV
Guidelines
Adopted
New
EudraVigilance
Format
China ICH
Guideline
Adopted
2016
ANVISA (Brazil)
ICH Guideline
Adopted
FDA IND
Cross
Reporting
China GVP
Brazil
VigiFlow
Rollout
FDA PBRER
Adopted
Mexico R3
(Cofepris)
PMDA
R3
Korea
MFDS R3
EMA R3
Brexit –
MHRA
Russia, TGA,
SAHPRA
Updates
FDA
Combo
Products
FDA E2B R3,
eVAERS, eMDR
Health
Canada R3
Looking to the Future
Simplifying Global Reporting
12
Copyright © Veeva Systems 2021
Analysis
Reporting & Metrics
Processing
Intake
Oversight & Management
Submissions
Gateway
Current PV System Landscape
Signal
Tracking
Local
Reporting
Business Objects
– Case
Management
Cognos, Qlik –
Metrics & user
reporting
Signal
Detection
Case
Analysis
Signal
Management –
Real Time
Analysis of
Clinical Cases
Compliance
Tracking &
Remediation
PV Agreements
Tracking
Receipt &
Triage
Reconciliation
Log & Track
Safety Support
Issues
Japanese Safety
Database
Safety
Database
Dictionary &
Coding Mgt
Safety
Database
Copy
Data Mart
PSMF, Local Trackers,
Safety Letters,
Investigator
Communications
Document
Management
ROW
Document
Management
EU
Literature
Assessment
Follow-up Letters,
Clinical Queries
& Tracking
Aggregate
Reporting
13
Copyright © Veeva Systems 2021
Challenges
Current PV System Landscape
Opportunities
• Technology
 Secure and manage data easily
 Maintaining data privacy
 Translation engines
 Analytics and Visualization of multi-
dimensional data
• Standardization
 Data format - E2B R2/R3
 Coding of medical products and events -
MedDRA (EMA, FDA), WHO DRUG, ATC
• Multiple data sources
• HQ & Affiliate model – siloed data sources
• Unstructured data
• Inconsistent coding
• Different languages
• Separate data and content systems
• Data Governance & Management
14
Copyright © Veeva Systems 2021
Unified and Connected Pharmacovigilance Solution
Aggregate or
Periodic Reporting
Case
Intake
Partner
Management
Content
Management
Case Processing
and Management
Submissions and
Distribution
Signal & Risk
Management
Artificial Intelligence, Reporting, Analytics, Dashboards
Other Data
Sources
Partners
Other
Functional
Areas
• Cloud R&D Platform
Unified Safety System
15
Copyright © Veeva Systems 2021
Traditional ICSR Reporting Process
Reporting & Metrics
Processing
Intake
Submissions
Gateway
Local
Reporting
Business Objects –
Case Management
Cognos, Qlik –
Metrics & user
reporting
Receipt &
Triage
Reconciliation
Log & Track
Safety Support
Issues
Japanese Safety
Database
Safety
Database
Dictionary &
Coding
Management
Safety
Database
Copy
Literature
Assessment
Follow-up Letters,
Clinical Queries
& Tracking
Aggregate
Reporting
16
Copyright © Veeva Systems 2021
Modern ICSR Reporting Process
Reporting & Metrics
Case Review
Intake & Processing
Submissions
Gateway
Global
Reporting
Metrics & O
Metrics & user
reporting
Receipt, Triage, Data Entry
Safety
Database
Follow-up Letters,
Clinical Queries
& Tracking
Aggregate
Reporting
QC & Med Review, Submission
Multilingual
Multilingual
Local
Reporting
Dictionary &
Coding
Management
CAPA
Tracking
17
Copyright © Veeva Systems 2021
Modern ICSR Reporting Process -
Identify and Review Late Submissions
18
Copyright © Veeva Systems 2021
Modern ICSR Reporting Process -
Analyze Late Submissions
19
Copyright © Veeva Systems 2021
Integrated with clinical,
regulatory and quality systems
Accessible from anywhere
and with any device
One source of the truth
Advanced automation and
intelligence
Unified Accessible Integrated AI
Cloud Always current with regulations
and new technologies
Power of a Unified Solution
Seamless Management of your Data & Content
20
Copyright © Veeva Systems 2021
Cloud Always current with regulations
and new technologies
AI and
AUTOMATION
DATA ANALYSIS CONTENT
Case Processing
Reporting
Submissions
Signal Detection
& Analysis
Risk Management
Content Management
Process Management
Intake
Data Entry
Follow-up
Unified Solution - PV Process Transformation
21
Copyright © Veeva Systems 2021
Benefits to the Industry
Technology Enabled
Simplified
ICSR Reporting
Simplified IT system
Landscape
Adaptive and
Scalable
Process Optimization
and Efficiency
Enhanced Collaboration and
Safety Content Management
Support Global and
Regional Reporting
Questions
Thank you
• Mike Kruczek
• Director, Vault Safety Strategy
• Mike.Kruczek@veeva.com
• (586) 216-8105
• Saba Darvesh
• Sr. Director, Vault Safety Strategy
• Saba.Darvesh@veeva.com
• (646) 463-2919

More Related Content

PPTX
Presentation on US FDA Data Integrity Guidance.
PPT
Challenges In Pharmacovigilance Dr Vishwas, by Dr. Vishwas Sovani MD ,VP P...
PDF
New Directions in Drug Approval in Canada
PPTX
WHODrug as linked data
PDF
FDA Regulation of Medical Devices
PPT
Volume 9 A Guidelines On Pharmacovigilance[1]
PDF
10 Facts to pass the RAC (Regulatory Affairs Certification)
PPTX
Presentation on US FDA Data Integrity Guidance.
Challenges In Pharmacovigilance Dr Vishwas, by Dr. Vishwas Sovani MD ,VP P...
New Directions in Drug Approval in Canada
WHODrug as linked data
FDA Regulation of Medical Devices
Volume 9 A Guidelines On Pharmacovigilance[1]
10 Facts to pass the RAC (Regulatory Affairs Certification)

What's hot (20)

PPTX
Presentation: Global pharmacovigilance networks - A regulator's
PDF
Practical Signal Management
PPTX
Understanding 21 cfr part 11
PDF
Risk Based Classification of Medical Devices and grouping
PPT
Remote Patient Monitoring (RPM) - Enabling New Models of Care
PPT
Drug Safety Regulations In The Us And Eu
PDF
Introduction to Pharmacovigilance Signal Detection
PPTX
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
PDF
TMF PDF.pdf
PDF
NEW DRUG APPLICATION( PHARMACY LAW AND ETHICS)
PPSX
Source Documents in Clinical Trials_part1
PPTX
CDSCO - Central Licensing Authority
PPTX
Pharmacovigilance Inspections
PPT
Hatch waxman act
PPT
Expectedness/Unexpectedness Assessment_Katalyst HLS
PDF
Clinical data management
PDF
Signal Detection & Management Strategies
PPTX
Pharmacovigilance
PPTX
Building a Foundation for Proactive and Predictive Pharmacovigilance
PPTX
Pharmacovigilance regulations as per European Union
Presentation: Global pharmacovigilance networks - A regulator's
Practical Signal Management
Understanding 21 cfr part 11
Risk Based Classification of Medical Devices and grouping
Remote Patient Monitoring (RPM) - Enabling New Models of Care
Drug Safety Regulations In The Us And Eu
Introduction to Pharmacovigilance Signal Detection
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
TMF PDF.pdf
NEW DRUG APPLICATION( PHARMACY LAW AND ETHICS)
Source Documents in Clinical Trials_part1
CDSCO - Central Licensing Authority
Pharmacovigilance Inspections
Hatch waxman act
Expectedness/Unexpectedness Assessment_Katalyst HLS
Clinical data management
Signal Detection & Management Strategies
Pharmacovigilance
Building a Foundation for Proactive and Predictive Pharmacovigilance
Pharmacovigilance regulations as per European Union
Ad

Similar to Reshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight (20)

PDF
Reimagine patient safety 2030 governance through a unified safety platform
PDF
Moving to unified PV: Transforming Safety with End-to-end PV Solutions
PPTX
Pharmacovigilance systems & methodologies across the globe
PDF
Transforming Pharmacovigilance from Operational to Scientifically Driven
PPTX
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
PPTX
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
PDF
ICH Guidelines for Pharmacovigilance.pdf
PPTX
Redesigning post-market safety surveillance
PPT
Pharmacovigilance Practice In
PPTX
Clinlogix - Improving Pharmacovigilance Outsourcing with Modern Technologies
PPTX
Pharmacovigilance overview
PPTX
Pharmacovigilance system-updated 2025.pptx
PPS
Ibara Michael Aster Ppt Show
PDF
Handouts.pdf
PDF
1st CUTEHeart Workshop Resnic Presentation
PDF
Advanced Methodologies in Pharmacovigilance
PPT
GOOD PHARMACOVIGILANCE PRACTICES
PPTX
Pharmacovigilance and Drug Safety Software Market PPT 2024: Size, Growth, Dem...
PDF
How Will the Updated EudraVigilance System Impact Pharma Companies and the In...
PPTX
vigiflow
Reimagine patient safety 2030 governance through a unified safety platform
Moving to unified PV: Transforming Safety with End-to-end PV Solutions
Pharmacovigilance systems & methodologies across the globe
Transforming Pharmacovigilance from Operational to Scientifically Driven
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
ICH Guidelines for Pharmacovigilance.pdf
Redesigning post-market safety surveillance
Pharmacovigilance Practice In
Clinlogix - Improving Pharmacovigilance Outsourcing with Modern Technologies
Pharmacovigilance overview
Pharmacovigilance system-updated 2025.pptx
Ibara Michael Aster Ppt Show
Handouts.pdf
1st CUTEHeart Workshop Resnic Presentation
Advanced Methodologies in Pharmacovigilance
GOOD PHARMACOVIGILANCE PRACTICES
Pharmacovigilance and Drug Safety Software Market PPT 2024: Size, Growth, Dem...
How Will the Updated EudraVigilance System Impact Pharma Companies and the In...
vigiflow
Ad

More from Veeva Systems (20)

PPTX
Strategies and Best Practices for Transforming Enterprise Training
PDF
The Industry’s Move Toward Digitally Connected Clinical Trials
PPTX
Enabling Proactive Quality Management Across Quality and Manufacturing
PPTX
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...
PPTX
Tufts Research: EDC Trends, Insights, and Opportunities
PPTX
Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
PDF
Webinar: Rethinking the Life Sciences Training Technology Ecosystem
PPTX
Validation strategies for cloud-based EDCs: more innovation, less effort
PPTX
Vertex Reduces EDC Study Build Times by 50%
PPTX
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
PPTX
PICI’s Best Practices for Building Oncology Studies in an EDC
PPTX
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution
PPTX
Unify quality manufacturing to drive speed, compliance and collaboration
PPTX
Shorten Database Builds by 60% with Agile Design
PPTX
Best practices for implementing and maintaining successful standards
PPTX
Designing an EDC System to Work for a CRA
PDF
Veeva Systems Webinar: Driving Continuous Quality Improvements
PPTX
University of Louisville: Enabling Research During COVID-19 and Beyond
PDF
Immunomedics: Transforming TMF Operations
PDF
GSK: Preparing the Business for Study Start-up Change
Strategies and Best Practices for Transforming Enterprise Training
The Industry’s Move Toward Digitally Connected Clinical Trials
Enabling Proactive Quality Management Across Quality and Manufacturing
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...
Tufts Research: EDC Trends, Insights, and Opportunities
Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
Webinar: Rethinking the Life Sciences Training Technology Ecosystem
Validation strategies for cloud-based EDCs: more innovation, less effort
Vertex Reduces EDC Study Build Times by 50%
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
PICI’s Best Practices for Building Oncology Studies in an EDC
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution
Unify quality manufacturing to drive speed, compliance and collaboration
Shorten Database Builds by 60% with Agile Design
Best practices for implementing and maintaining successful standards
Designing an EDC System to Work for a CRA
Veeva Systems Webinar: Driving Continuous Quality Improvements
University of Louisville: Enabling Research During COVID-19 and Beyond
Immunomedics: Transforming TMF Operations
GSK: Preparing the Business for Study Start-up Change

Recently uploaded (20)

PDF
Electronic commerce courselecture one. Pdf
PDF
Diabetes mellitus diagnosis method based random forest with bat algorithm
PDF
Reach Out and Touch Someone: Haptics and Empathic Computing
PPTX
Understanding_Digital_Forensics_Presentation.pptx
PDF
CIFDAQ's Market Insight: SEC Turns Pro Crypto
PDF
7 ChatGPT Prompts to Help You Define Your Ideal Customer Profile.pdf
PDF
Encapsulation_ Review paper, used for researhc scholars
PPTX
Detection-First SIEM: Rule Types, Dashboards, and Threat-Informed Strategy
PDF
Modernizing your data center with Dell and AMD
PDF
Blue Purple Modern Animated Computer Science Presentation.pdf.pdf
PDF
NewMind AI Weekly Chronicles - August'25 Week I
PPT
“AI and Expert System Decision Support & Business Intelligence Systems”
PDF
Mobile App Security Testing_ A Comprehensive Guide.pdf
PDF
Chapter 3 Spatial Domain Image Processing.pdf
PPTX
A Presentation on Artificial Intelligence
PDF
Bridging biosciences and deep learning for revolutionary discoveries: a compr...
PDF
Build a system with the filesystem maintained by OSTree @ COSCUP 2025
PPTX
Digital-Transformation-Roadmap-for-Companies.pptx
PDF
The Rise and Fall of 3GPP – Time for a Sabbatical?
PDF
Machine learning based COVID-19 study performance prediction
Electronic commerce courselecture one. Pdf
Diabetes mellitus diagnosis method based random forest with bat algorithm
Reach Out and Touch Someone: Haptics and Empathic Computing
Understanding_Digital_Forensics_Presentation.pptx
CIFDAQ's Market Insight: SEC Turns Pro Crypto
7 ChatGPT Prompts to Help You Define Your Ideal Customer Profile.pdf
Encapsulation_ Review paper, used for researhc scholars
Detection-First SIEM: Rule Types, Dashboards, and Threat-Informed Strategy
Modernizing your data center with Dell and AMD
Blue Purple Modern Animated Computer Science Presentation.pdf.pdf
NewMind AI Weekly Chronicles - August'25 Week I
“AI and Expert System Decision Support & Business Intelligence Systems”
Mobile App Security Testing_ A Comprehensive Guide.pdf
Chapter 3 Spatial Domain Image Processing.pdf
A Presentation on Artificial Intelligence
Bridging biosciences and deep learning for revolutionary discoveries: a compr...
Build a system with the filesystem maintained by OSTree @ COSCUP 2025
Digital-Transformation-Roadmap-for-Companies.pptx
The Rise and Fall of 3GPP – Time for a Sabbatical?
Machine learning based COVID-19 study performance prediction

Reshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight

  • 1. 1 Copyright © Veeva Systems 2021 Reshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight Saba Darvesh, Sr. Director Vault Safety Strategy Mike Kruczek, Director Vault Safety Strategy
  • 2. Saba Darvesh Sr. Director, Vault Safety Strategy Mike Kruczek Director, Vault Safety Strategy
  • 4. 4 Copyright © Veeva Systems 2021 ICSR Volume Data FDA FAERS Public Dashboard (Mar 2021)
  • 5. 5 Copyright © Veeva Systems 2021 ICSR Volume Data EMA PV Annual Report (2020) Figure 2 – Trend of ADR reports from patients and consumers received in the EEA by NCAs and MAHs and reported to EudraVigilance EudraVigilance continues to support the reporting of suspected unexpected serious adverse reactions (SUSARs) in accordance with EU clinical trial legislation14 (see Annex II)
  • 6. 6 Copyright © Veeva Systems 2021 ICSR Volume Data NMPA PV Annual Report (2020) 1800000 1600000 1400000 1200000 1000000 800000 600000 400000 200000 0 Figure 1 - Trend in the number of reported adverse drug reactions / events nationwide from 1999 to 2020 Figure 3 - Source of adverse drug event reports for 2020
  • 7. 7 Copyright © Veeva Systems 2021 Uppsala Monitoring Centre Annual Report Jul 2019 – Jun 2020 Additional Statistics from VigiBase Country distribution for ICSRs received over the year Country distribution in VigiBase for ICSRs received during the past 12 months, as of 30 June 2020 ICSRs per Million Inhabitants ICSRs received in VigiBase 2015 – 2020 (average to compensate for year-to-year fluctuations)
  • 8. A Rapidly Evolving Global Reporting Landscape
  • 9. 9 Copyright © Veeva Systems 2021 Evolving Global Reporting Landscape Evolving Regulatory Guidelines File Formats Data Integrity and Timeliness Solicited Monitoring Unsolicited Monitoring (PSP’s, SM, MLM) Data Quality Enhanced Oversight and Management
  • 10. 10 Copyright © Veeva Systems 2021 Evolving Global Regulatory Landscape 2001 EudraVigilance Created 2012 2017 2018 2019 2020 2021 New EU GPV Guidelines Adopted New EudraVigilance Format China ICH Guideline Adopted 2016 ANVISA (Brazil) ICH Guideline Adopted FDA IND Cross Reporting China GVP Brazil VigiFlow Rollout FDA PBRER Adopted Mexico R3 (Cofepris) PMDA R3 Korea MFDS R3 EMA R3 Brexit – MHRA Russia, TGA, SAHPRA Updates FDA Combo Products FDA E2B R3, eVAERS, eMDR Health Canada R3
  • 11. Looking to the Future Simplifying Global Reporting
  • 12. 12 Copyright © Veeva Systems 2021 Analysis Reporting & Metrics Processing Intake Oversight & Management Submissions Gateway Current PV System Landscape Signal Tracking Local Reporting Business Objects – Case Management Cognos, Qlik – Metrics & user reporting Signal Detection Case Analysis Signal Management – Real Time Analysis of Clinical Cases Compliance Tracking & Remediation PV Agreements Tracking Receipt & Triage Reconciliation Log & Track Safety Support Issues Japanese Safety Database Safety Database Dictionary & Coding Mgt Safety Database Copy Data Mart PSMF, Local Trackers, Safety Letters, Investigator Communications Document Management ROW Document Management EU Literature Assessment Follow-up Letters, Clinical Queries & Tracking Aggregate Reporting
  • 13. 13 Copyright © Veeva Systems 2021 Challenges Current PV System Landscape Opportunities • Technology  Secure and manage data easily  Maintaining data privacy  Translation engines  Analytics and Visualization of multi- dimensional data • Standardization  Data format - E2B R2/R3  Coding of medical products and events - MedDRA (EMA, FDA), WHO DRUG, ATC • Multiple data sources • HQ & Affiliate model – siloed data sources • Unstructured data • Inconsistent coding • Different languages • Separate data and content systems • Data Governance & Management
  • 14. 14 Copyright © Veeva Systems 2021 Unified and Connected Pharmacovigilance Solution Aggregate or Periodic Reporting Case Intake Partner Management Content Management Case Processing and Management Submissions and Distribution Signal & Risk Management Artificial Intelligence, Reporting, Analytics, Dashboards Other Data Sources Partners Other Functional Areas • Cloud R&D Platform Unified Safety System
  • 15. 15 Copyright © Veeva Systems 2021 Traditional ICSR Reporting Process Reporting & Metrics Processing Intake Submissions Gateway Local Reporting Business Objects – Case Management Cognos, Qlik – Metrics & user reporting Receipt & Triage Reconciliation Log & Track Safety Support Issues Japanese Safety Database Safety Database Dictionary & Coding Management Safety Database Copy Literature Assessment Follow-up Letters, Clinical Queries & Tracking Aggregate Reporting
  • 16. 16 Copyright © Veeva Systems 2021 Modern ICSR Reporting Process Reporting & Metrics Case Review Intake & Processing Submissions Gateway Global Reporting Metrics & O Metrics & user reporting Receipt, Triage, Data Entry Safety Database Follow-up Letters, Clinical Queries & Tracking Aggregate Reporting QC & Med Review, Submission Multilingual Multilingual Local Reporting Dictionary & Coding Management CAPA Tracking
  • 17. 17 Copyright © Veeva Systems 2021 Modern ICSR Reporting Process - Identify and Review Late Submissions
  • 18. 18 Copyright © Veeva Systems 2021 Modern ICSR Reporting Process - Analyze Late Submissions
  • 19. 19 Copyright © Veeva Systems 2021 Integrated with clinical, regulatory and quality systems Accessible from anywhere and with any device One source of the truth Advanced automation and intelligence Unified Accessible Integrated AI Cloud Always current with regulations and new technologies Power of a Unified Solution Seamless Management of your Data & Content
  • 20. 20 Copyright © Veeva Systems 2021 Cloud Always current with regulations and new technologies AI and AUTOMATION DATA ANALYSIS CONTENT Case Processing Reporting Submissions Signal Detection & Analysis Risk Management Content Management Process Management Intake Data Entry Follow-up Unified Solution - PV Process Transformation
  • 21. 21 Copyright © Veeva Systems 2021 Benefits to the Industry Technology Enabled Simplified ICSR Reporting Simplified IT system Landscape Adaptive and Scalable Process Optimization and Efficiency Enhanced Collaboration and Safety Content Management Support Global and Regional Reporting
  • 23. Thank you • Mike Kruczek • Director, Vault Safety Strategy • Mike.Kruczek@veeva.com • (586) 216-8105 • Saba Darvesh • Sr. Director, Vault Safety Strategy • Saba.Darvesh@veeva.com • (646) 463-2919